News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,489 Results
Type
Article (41791)
Company Profile (268)
Press Release (694419)
Multimedia
Podcasts (83)
Webinars (17)
Section
Business (208878)
Career Advice (2056)
Deals (36178)
Drug Delivery (110)
Drug Development (82283)
Employer Resources (173)
FDA (16677)
Job Trends (15557)
News (352889)
Policy (33627)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2752)
Accelerated approval (33)
Adcomms (26)
Allergies (139)
Alliances (50516)
ALS (169)
Alzheimer's disease (1703)
Antibody-drug conjugate (ADC) (314)
Approvals (16946)
Artificial intelligence (512)
Autoimmune disease (147)
Automation (37)
Bankruptcy (363)
Best Places to Work (12234)
BIOSECURE Act (20)
Biosimilars (191)
Biotechnology (175)
Bladder cancer (158)
Brain cancer (58)
Breast cancer (643)
Cancer (4836)
Cardiovascular disease (402)
Career advice (1738)
Career pathing (35)
CAR-T (284)
CDC (44)
Celiac Disease (2)
Cell therapy (746)
Cervical cancer (37)
Clinical research (70169)
Collaboration (1723)
Company closure (4)
Compensation (1138)
Complete response letters (52)
COVID-19 (2778)
CRISPR (89)
C-suite (835)
Cystic fibrosis (144)
Data (6210)
Decentralized trials (2)
Denatured (25)
Depression (136)
Diabetes (504)
Diagnostics (6903)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (248)
Drug pricing (185)
Drug shortages (28)
Duchenne muscular dystrophy (229)
Earnings (91184)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (120687)
Executive appointments (976)
FDA (19819)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1486)
Gene editing (196)
Generative AI (42)
Gene therapy (600)
GLP-1 (973)
Government (4828)
Grass and pollen (6)
Guidances (384)
Healthcare (20107)
HIV (55)
Huntington's disease (46)
IgA nephropathy (82)
Immunology and inflammation (252)
Immuno-oncology (54)
Indications (104)
Infectious disease (3042)
Inflammatory bowel disease (193)
Inflation Reduction Act (14)
Influenza (115)
Intellectual property (244)
Interviews (322)
IPO (16993)
IRA (49)
Job creations (3667)
Job search strategy (1452)
JPM (58)
Kidney cancer (15)
Labor market (83)
Layoffs (553)
Leadership (32)
Legal (8187)
Liver cancer (93)
Longevity (14)
Lung cancer (646)
Lymphoma (373)
Machine learning (43)
Management (59)
Manufacturing (795)
MASH (162)
Medical device (14290)
Medtech (14344)
Mergers & acquisitions (20264)
Metabolic disorders (1269)
Multiple sclerosis (156)
NASH (17)
Neurodegenerative disease (310)
Neuropsychiatric disorders (88)
Neuroscience (2930)
Neurotech (1)
NextGen: Class of 2026 (7074)
Non-profit (4924)
Now hiring (65)
Obesity (595)
Opinion (263)
Ovarian cancer (165)
Pain (201)
Pancreatic cancer (227)
Parkinson's disease (281)
Partnered (34)
Patents (494)
Patient recruitment (476)
Peanut (56)
People (60304)
Pharmaceutical (62)
Pharmacy benefit managers (30)
Phase 1 (21924)
Phase 2 (30893)
Phase 3 (22963)
Pipeline (5118)
Policy (280)
Postmarket research (2584)
Preclinical (9300)
Press Release (72)
Prostate cancer (235)
Psychedelics (47)
Radiopharmaceuticals (284)
Rare diseases (829)
Real estate (6092)
Recruiting (69)
Regulatory (25003)
Reports (51)
Research institute (2503)
Resumes & cover letters (357)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (151)
Series A (245)
Series B (189)
Service/supplier (11)
Sickle cell disease (96)
Special edition (27)
Spinal muscular atrophy (158)
Sponsored (41)
Startups (3694)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (84)
The Weekly (56)
Vaccines (1001)
Venture capital (87)
Weight loss (384)
Women's health (87)
Worklife (18)
Date
Last 7 days (599)
Last 30 days (1969)
Last 365 days (30245)
2026 (2856)
2025 (30711)
2024 (35968)
2023 (41061)
2022 (52189)
2021 (56979)
2020 (55915)
2019 (49248)
2018 (37150)
2017 (32845)
2016 (32417)
2015 (38418)
2014 (31543)
2013 (26549)
2012 (28762)
2011 (29460)
2010 (27497)
Location
Africa (766)
Alabama (90)
Alaska (7)
Arizona (310)
Arkansas (14)
Asia (40501)
Australia (6533)
California (11243)
Canada (3267)
China (1122)
Colorado (475)
Connecticut (474)
Delaware (336)
Europe (87455)
Florida (1678)
Georgia (359)
Hawaii (3)
Idaho (65)
Illinois (893)
India (64)
Indiana (521)
Iowa (23)
Japan (424)
Kansas (129)
Kentucky (42)
Louisiana (27)
Maine (73)
Maryland (1407)
Massachusetts (8094)
Michigan (339)
Minnesota (648)
Mississippi (6)
Missouri (126)
Montana (35)
Nebraska (28)
Nevada (125)
New Hampshire (84)
New Jersey (2989)
New Mexico (30)
New York (2963)
North Carolina (1468)
North Dakota (9)
Northern California (5472)
Ohio (337)
Oklahoma (22)
Oregon (42)
Pennsylvania (2266)
Puerto Rico (22)
Rhode Island (48)
South America (1154)
South Carolina (67)
South Dakota (1)
Southern California (4380)
Tennessee (173)
Texas (1756)
United States (40116)
Utah (341)
Vermont (1)
Virginia (274)
Washington D.C. (83)
Washington State (924)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
736,489 Results for "origin inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
December 11, 2025
·
7 min read
Press Releases
Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs
September 26, 2025
·
5 min read
Press Releases
Selonterra announces grant of United States patent on original discoveries in Alzheimer’s disease
August 19, 2025
·
1 min read
Press Releases
Children’s Hospital Los Angeles Researchers Discover Possible Cell of Origin for Ewing Sarcoma
October 13, 2025
·
5 min read
Press Releases
Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET
October 23, 2025
·
7 min read
Press Releases
Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine
November 7, 2025
·
9 min read
Press Releases
Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025
October 20, 2025
·
6 min read
Clinical research
Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A
The patient, who died on December 14, was originally enrolled in a Phase III study in 2022 and transitioned into an extension phase in 2023.
December 23, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin
June 25, 2025
·
8 min read
Mergers & acquisitions
UPDATE: Avadel Accepts Alkermes’ Revised $2.37B Counteroffer, Besting Lundbeck
Lundbeck had tried to scoop the narcolepsy drug maker out from under Alkeremes with $2.4 billion, but Avadel has elected to go with its original suitor.
November 19, 2025
·
3 min read
·
Tristan Manalac
1 of 73,649
Next
